Brain+
0.021
DKK
+5.05 %
Less than 1K followers
BRAINP
First North Denmark
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
+5.05%
-41.24%
-50.79%
-55.41%
-57.32%
-65.6%
-97.58%
-
-98.48%
Brain+ are a pharmaceutical company. The company specializes in research and development for the treatment of dementia and Alzheimer's. The product portfolio includes, for example, cognitive stimulation therapy. In addition to the main business, service and associated ancillary services are also offered. The business is run with the largest presence in Europe. Brain+ is headquartered in Copenhagen.
Read moreMarket cap
13.58M DKK
Turnover
34.64K DKK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
29.4
2025
Annual report '24
29.5
2025
General meeting '25
28.8
2025
Interim report Q2'25
All
Press releases
3rd party
ShowingAll content types
Brain+ A/S: Brain+ announces directed issue of units to convertible loan providers and guarantors
Brain+ A/S: Contract signed with Copenhagen Municipality on extended and expanded access to Ayla
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools